Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies &a
Go back to Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies &a| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.32 -0.02 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.34 | 52 Week High | $19.62 | |||
| Open | $2.35 | 52 Week Low | $7.65 | |||
| Day High | $2.44 | P/E | N/A | |||
| Day Low | $2.27 | EPS | $-0.22 | |||
| Volume | 2,630,012 | |||||
